Search Results - "Boberg, K M"

Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis by Karlsen, T. H., Vesterhus, M., Boberg, K. M.

“…Summary Background Despite considerable advances over the last two decades in the molecular understanding of cholestasis and cholestatic liver disease, little…”
Get full text

Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma by Bernuzzi, F., Marabita, F., Lleo, A., Carbone, M., Mirolo, M., Marzioni, M., Alpini, G., Alvaro, D., Boberg, K. M., Locati, M., Torzilli, G., Rimassa, L., Piscaglia, F., He, X.‐S., Bowlus, C. L., Yang, G.‐X., Gershwin, M. E., Invernizzi, P.

“…Summary The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and specific biomarkers, as is the early diagnosis of…”
Get full text

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia by Lindström, L., Boberg, K. M., Wikman, O., Friis-Liby, I., Hultcrantz, R., Prytz, H., Sandberg-Gertzén, H., Sangfelt, P., Rydning, A., Folvik, G., Gangsøy-Kristiansen, M., Danielsson, Å., Bergquist, Annika

“…Summary Background Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) have a high risk of developing colorectal cancer and…”
Get full text

Incidence and Prevalence of Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Autoimmune Hepatitis in a Norwegian Population by BOBERG, K. M, AADLAND, E, JAHNSEN, J, RAKNERUD, N, STIRIS, M, BELL, H

“…Background: The relative frequencies of the autoimmune liver diseases primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmune…”
Get full text

Decreasing incidence of cancer after liver transplantation—A Nordic population‐based study over 3 decades by Nordin, A., Åberg, F., Pukkala, E., Pedersen, C. R., Storm, H. H., Rasmussen, A., Bennet, W., Olausson, M., Wilczek, H., Ericzon, B.‐G., Tretli, S., Line, P.‐D., Karlsen, T. H., Boberg, K. M., Isoniemi, H.

“…Cancer remains one of the most serious long‐term complications after liver transplantation (LT). Data for all adult LT patients between 1982 and 2013 were…”
Get full text

Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis by Björnsson, E, Boberg, K M, Cullen, S, Fleming, K, Clausen, O P, Fausa, O, Schrumpf, E, Chapman, R W

“…Background: Patients with cholestatic liver function tests and histological features of primary sclerosing cholangitis (PSC) but a normal cholangiogram are…”
Get full text

Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation by Boberg, K. M., Bergquist, A., Mitchell, S., Pares, A., Rosina, F., Broomé, U., Chapman, R., Fausa, O., Egeland, T., Rocca, G., Schrumpf, E.

“…Background: Primary sclerosing cholangitis (PSC) confers a high risk of cholangiocarcinoma (CC) development. Since patients at risk of CC may be selected for…”
Get full text

Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid by Boberg, K. M., Wisløff, T., Kjøllesdal, K. S., Støvring, H., Kristiansen, I. S.

“…Summary Background Long‐term use of ursodeoxycholic acid (UDCA) is the recommended therapy in primary biliary cirrhosis (PBC). The lifetime effectiveness and…”
Get full text

Current consensus on the management of primary sclerosing cholangitis by Wiencke, K, Boberg, K.M

“…Summary Guidelines for the management of primary sclerosing cholangitis (PSC) have recently been published by both the European Association for the Study of…”
Get full text

Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients by BOBERG, K. M, EGELAND, T, SCHRUMPF, E

“…Background: A beneficial effect of corticosteroids in primary sclerosing cholangitis (PSC) has been suggested, but characteristics of responding patients and…”
Get full text

Association of UCP2 −866 G A polymorphism with chronic inflammatory diseases by Yu, X, Wieczorek, S, Franke, A, Yin, H, Pierer, M, Sina, C, Karlsen, T H, Boberg, K M, Bergquist, A, Kunz, M, Witte, T, Gross, W L, Epplen, J T, Alarcón-Riquelme, M E, Schreiber, S, Ibrahim, S M

“…We reported earlier that two mitochondrial gene polymorphisms, UCP2 –866 G/A (rs659366) and mtDNA nt13708 G/A (rs28359178), are associated with multiple…”
Get full text

Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases by Viken, M K, Amundsen, S S, Kvien, T K, Boberg, K M, Gilboe, I M, Lilleby, V, Sollid, L M, Førre, O T, Thorsby, E, Smerdel, A, Lie, B A

“…A functional single nucleotide polymorphism, 1858C>T, in the PTPN22 gene, encoding a tyrosine phosphatase, has been reported to be associated with type I…”
Get full text

The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases by Eike, M C, Nordang, G B N, Karlsen, T H, Boberg, K M, Vatn, M H, Dahl-Jørgensen, K, Rønningen, K S, Joner, G, Flatø, B, Bergquist, A, Thorsby, E, Førre, O, Kvien, T K, Undlien, D E, Lie, B A

“…The Fc receptor-like 3 (FCRL3) gene -169T>C single nucleotide polymorphism (SNP) has been reported to be associated with several autoimmune diseases (AIDs) in…”
Get more information

Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis by Mitchell, S A, Grove, J, Spurkland, A, Boberg, K M, Fleming, K A, Day, C P, Schrumpf, E, Chapman, R W

“…BACKGROUND AND AIMS Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology. Abnormalities in immune regulation and…”
Get full text

Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis by Boberg, K M, Fausa, O, Haaland, T, Holter, E, Mellbye, O J, Spurkland, A, Schrumpf, E

“…Overlapping features between primary sclerosing cholangitis (PSC and autoimmune hepatitis (AIH) have previously been noted. To assess systematically…”
Get full text

Acute liver graft rejection after ipilimumab therapy by Dueland, S., Guren, T.K., Boberg, K.M., Reims, H.M., Grzyb, K., Aamdal, S., Julsrud, L., Line, P.D.

Get full text

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis by Karlsen, T H, Boberg, K M, Vatn, M, Bergquist, A, Hampe, J, Schrumpf, E, Thorsby, E, Schreiber, S, Lie, B A

“…Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have inflammatory bowel disease (IBD), the majority…”
Get full text

Serological markers of extracellular matrix remodeling predict transplant‐free survival in primary sclerosing cholangitis by Nielsen, M. J., Thorburn, D., Leeming, D. J., Hov, J. R., Nygård, S., Moum, B., Saffioti, F., Gilja, O. H., Boberg, K. M., Mazza, G., Røsjø, H., Pinzani, M., Karlsen, T. H., Karsdal, M. A., Vesterhus, M.

“…Summary Background Primary sclerosing cholangitis is a progressive liver disease with a remarkably variable course. Biomarkers of disease activity or…”
Get full text

Hepatic and extrahepatic malignancies and primary sclerosing cholangitis by Schrumpf, E, Boberg, K M

Get full text

Cholangiocarcinoma in primary sclerosing cholangitis : K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development by BOBERG, K. M, SCHRUMPF, E, BERGQUIST, A, BROOME, U, PARES, A, REMOTTI, H, SCHJÖLBERG, A, SPURKLAND, A, CLAUSEN, O. P. F

“…Cholangiocarcinoma is a feared complication of primary sclerosing cholangitis (PSC). Neoplastic bile duct strictures may be difficult to differentiate…”
Get full text